PACIFICHEALTH LABORATORIES INC
POS AM, 1997-12-19
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: PACIFICHEALTH LABORATORIES INC, 424B1, 1997-12-19
Next: MARKETVEST FUNDS, 497, 1997-12-19




<PAGE>

   
   AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON DECEMBER 19, 1997.
    
 
                                                      REGISTRATION NO. 333-36379
================================================================================
 
                       SECURITIES AND EXCHANGE COMMISSION
 
                             WASHINGTON, D.C. 20549
 
                            ------------------------
 
   
                                 POST EFFECTIVE
                                AMENDMENT NO. 1
    
 
                                   FORM SB-2
 
            REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
 
                            ------------------------
 
                        PACIFICHEALTH LABORATORIES, INC.
 
                 (NAME OF SMALL BUSINESS ISSUER IN ITS CHARTER)
 
<TABLE>
<S>                               <C>                               <C>
           DELAWARE                            5122                          22-3367588
  (STATE OR JURISDICTION OF        (PRIMARY STANDARD INDUSTRIAL            (IRS EMPLOYER
INCORPORATION OR ORGANIZATION)     CLASSIFICATION CODE NUMBER)           IDENTIFICATION NO.)
</TABLE>
 
                            ------------------------
 
                               1460 ROUTE 9 NORTH
                              WOODBRIDGE, NJ 07095
                                  732/636-6141
 
         (ADDRESS AND TELEPHONE NUMBER OF PRINCIPAL EXECUTIVE OFFICES)
 
                   JONATHAN D. RAHN, EXECUTIVE VICE PRESIDENT
                               1460 ROUTE 9 NORTH
                              WOODBRIDGE, NJ 07095
                             TELEPHONE 732/636-6141
                             FACSIMILE 732/636-7410
 
           (NAME, ADDRESS AND TELEPHONE NUMBER OF AGENT FOR SERVICE)
 
                            ------------------------
 
                          Copies of communications to:
 
<TABLE>
<S>                                                 <C>
    JOSEPH CHICCO, ESQUIRE                            VICTOR J. DIGIOIA, ESQUIRE
CONNOLLY EPSTEIN CHICCO FOXMAN                        BRIAN C. DAUGHNEY, ESQUIRE
      ENGELMYER & EWING                                GOLDSTEIN & DIGIOIA, LLP
1515 MARKET STREET - 9TH FLOOR                           369 LEXINGTON AVENUE
    PHILADELPHIA, PA 19102                                NEW YORK, NY 10036
    TELEPHONE 215/851-8410                              TELEPHONE 212/599-3322
    FACSIMILE 215/851-8383                              FACSIMILE 212/557-0295
</TABLE>
 
       
 
================================================================================

<PAGE>


       


ITEM 27.  EXHIBITS.
 
   
     (a) Exhibits filed herewith:

Exhibit No.
- -----------
   4.4       Form of Promotional Shares Lock Up Agreement
   4.5       Form of Underwriter's Lock Up Agreement

     (b) Exhibits filed prior to effectiveness:
 
     Exhibits listed below either were filed with the Company's initial filing
of Form SB-2 on September 25, 1997(*), with Amendment No. 1 to Form SB-2 filed
October 23, 1997(**), or with Amendment No. 3 filed December 17, 1997(***).
    
 
<TABLE>
<CAPTION>
 EXHIBIT
   NO.
 -------
<S>        <C>   <C>
 ***1.1     --   Underwriting Agreement
 
 ***1.2     --   Selected Dealer Agreement
 
   *3.1     --   Certificate of Incorporation of the Company and all
                 amendments thereto
 
***3.2.1    --   Amended and Restated Bylaws of the Company
 
 ***4.1     --   Specimen Common Stock Certificate
 
 ***4.2     --   Underwriter's Warrant Agreement and Form of Warrant
 
   *4.3     --   Designation of 10% Convertible Preferred Stock
</TABLE>
 
                                      II-1
<PAGE>
<TABLE>
 EXHIBIT
   NO.
 -------
<S>        <C>   <C>
 ***5       --   Opinion of Connolly Epstein Chicco Foxman Engelmyer & Ewing
                 regarding the legality of securities being registered
 
  *10.1     --   Incentive Stock Option Plan of 1995
 
  *10.2     --   Employment Agreement between the Company and Robert Portman
                 dated May 1, 1995
 
***10.2.1   --   Employment Agreement between the Company and Robert Portman
                 effective January 1, 1998
 
  *10.3     --   Strategic Alliance Agreement between the Company and the
                 Institute of Nutrition and Food Hygiene
 
  *10.4     --   Exclusive License Agreement between the Company and the INFH
 
  *10.5     --   Shareholders Agreement
 
  *10.6     --   Big Sky, Inc. Endorsement Agreement
 
  *10.7     --   Big Sky, Inc. Option Agreement
 
    10.8    --   Financial Consulting Agreement between the Company and the
                 Underwriter
 
 **10.9     --   License and distribution letter agreement with Kemin Foods,
                 L.C. dated September 22, 1997
 
 **10.10    --   Credit Agreement with Summit Bank dated May 1, 1997
 
***23.1     --   Consent of Schiffman Hughes Brown
 
***23.2     --   Consent of Connolly Epstein Chicco Foxman Engelmyer & Ewing
                 (included in Exhibit 5)
 
  *24       --   Power of Attorney (included in the signature pages of the
                 Registration Statement)
 
***27       --   Financial Data Schedules
</TABLE>
 
       

 
                                      II-2
<PAGE>
                                   SIGNATURES
 
   
     In accordance with the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements of filing on Form SB-2 and authorized this Post-Effective
Amendment No. 1 to Registration Statement No. 333-36379 to be signed on its
behalf by the undersigned, in the City of Philadelphia, on the 19th day of
December, 1997.
    
 
                                    PACIFICHEALTH LABORATORIES, INC.
 
                                    By: /s /  ROBERT PORTMAN
                                       -----------------------------------------
                                        Robert Portman
                                        President and Chief Executive Officer
                                        and a Director
 
     In accordance with the requirements of the Securities Act of 1933, this
Registration Statement was signed by the following persons in the capacities and
on the dates stated.
 
<TABLE>
<CAPTION>
               SIGNATURE                     CAPACITY IN WHICH SIGNED             DATE
               ---------                     ------------------------             ----
<S>                                          <C>                           <C>
   
/s /  JONATHAN D. RAHN                       Chief Financial Officer,       December 19, 1997
- ---------------------------------------      Principal Accounting
Jonathan D. Rahn                             Officer and a Director
 
/s /  DAVID I. PORTMAN                       Director                       December 19, 1997
- ---------------------------------------
David I. Portman
</TABLE>
    
 
                                      II-3
<PAGE>
                                 EXHIBIT INDEX
 
<TABLE>
<CAPTION>
                                                                          SEQUENTIAL PAGE
EXHIBIT NO.                             DESCRIPTION                           NUMBER
- -----------                             -----------                       ---------------
<S>          <C>   <C>                                                    <C>
***1.1        --   Underwriting Agreement
 
***1.2        --   Selected Dealer Agreement
 
  *3.1        --   Certificate of Incorporation of the Company and all
                   amendments thereto
 
***3.2        --   Amended and Restated Bylaws of the Company
 
***4.1        --   Specimen Common Stock Certificate
 
***4.2        --   Underwriter's Warrant Agreement and Form of Warrant
 
  *4.3        --   Designation of 10% Convertible Preferred Stock
 
   
****4.4       --   Form of Promotional Shares Lock Up Agreement

****4.5       --   Form of Underwriter's Lock Up Agreement
    


***5          --   Opinion of Connolly Epstein Chicco Foxman Engelmyer &
                   Ewing regarding the legality of securities being
                   registered
 
  *10.1       --   Incentive Stock Option Plan of 1995
 
  *10.2       --   Employment Agreement between the Company and Robert
                   Portman dated May 1, 1995
 
***10.2.1     --   Employment Agreement between the Company and Robert
                   Portman effective January 1, 1998
 
  *10.3       --   Strategic Alliance Agreement between the Company and
                   the Institute of Nutrition and Food Hygiene
 
  *10.4       --   Exclusive Licensing Agreement between the Company and
                   the INFH
 
  *10.5       --   Shareholders Agreement
 
  *10.6       --   Big Sky, Inc. Endorsement Agreement
 
  *10.7       --   Big Sky, Inc. Option Agreement
 
  *10.8       --   Financial Consulting Agreement between the Company
                   and the Underwriter
 
 **10.9       --   License and distribution letter agreement with Kemin
                   Foods, L.C. dated September 22, 1997
 
 **10.10      --   Credit Agreement with Summit Bank dated May 1, 1997
 
***23.1       --   Consent of Schiffman Hughes Brown
 
***23.2       --   Consent of Connolly Epstein Chicco Foxman Engelmyer &
                   Ewing (included in Exhibit 5)
 
  *24         --   Power of Attorney (included in the signature pages of
                   the Registration Statement)
 
***27         --   Financial Data Schedules
</TABLE>
 
   
- ------------------
 *   Filed with Form SB-2 on September 25, 1997
 **  Filed with Amendment No. 1 to Form SB-2 on October 23, 1997
 *** Filed with Amendment No. 3 to Form SB-2 on December 17, 1997
**** Filed with Post Effective Amendment No. 1 on December 19, 1997
    




                        PACIFICHEALTH LABORATORIES, INC.

                      PROMOTIONAL SHARES LOCK-IN AGREEMENT


I.  This Promotional Shares Lock-In Agreement ("Agreement"), which was entered
    into on the 16th of December 1997, by and between PacificHealth
    Laboratories, Inc. ("Issuer"), whose principal place of business is located
    in Woodbridge, New Jersey, and _________________________ ("Security Holder")
    witnessed that:

    A.  The issuer has filed an application with the Pennsylvania Securities
        Commission (the "Commission") to register certain of its Equity
        Securities for sale to public investors who are residents of
        Pennsylvania ("Registration");

    B.  The Security Holder is the owner of shares of common stock or similar
        securities and/or possess convertible securities, warrants, options or
        rights which may be converted into, or exercised to purchase shares of
        common stock or similar securities of Issuer.

    C.  As a condition to Registration, the Issuer and Security Holder
        ("Signatories") agree to be bound by the terms of this Agreement.

II. THEREFORE, the Security Holder agrees not to sell, pledge, hypothecate, 
    assign, grant any option for the sale of, or otherwise transfer or dispose
    of, whether or not for consideration, directly or indirectly, the EQUITY
    SECURITIES as defined in the North American Securities Administrators
    Association ("NASAA") Statement of Policy on Corporate Securities
    Definitions set forth below and all certificates representing stock
    dividends, stock splits, recapitalizations, and the like, that are granted
    to, or received by, the Security Holder while the EQUITY SECURITIES are
    subject to this Agreement ("Restricted Securities").

    a.  Year one:

        Restricted Securities   -   all shares owned by the Security Holder

    b.  Year two:

        Restricted Securities   -   __________ shares of Common Stock

    Beginning one year from the completion date of the Issuer's public offering
    pursuant to the Registration, two and one-half percent (2 1/2%) of the
    Restricted Securities may be released each quarter pro rata among the
    Security Holders. All remaining Restricted Securities shall be released from
    escrow on the anniversary of the second year from the completion date of the
    public offering.


<PAGE>



III. THEREFORE, the Signatories agree and will cause the following:

     A. In the event of a dissolution, liquidation, merger, consolidation,
        reorganization, sale or exchange of the Issuer's assets or securities
        (including by way of tender offer), or any other transaction or
        proceeding with a person who is not a Promoter, which results in the
        distribution of the Issuer's assets or securities ("Distribution"),
        while this Agreement remains in effect that:

        1.  All holders of the Issuer's EQUITY SECURITIES will initially share
            on a pro rata, per share basis in the Distribution, in proportion to
            the amount of cash or other consideration that they paid per share
            for their EQUITY SECURITIES (provided that the Administrator has
            accepted the value of the other consideration), until the
            shareholders who purchased the Issuer's EQUITY SECURITIES pursuant
            to the public offering ("Public Shareholders") have received, or
            have had irrevocably set aside for them, an amount that is equal to
            one hundred percent (100%) of the public offering's price per share
            times the number of shares of EQUITY SECURITIES that they purchased
            pursuant to the public offering and which they still hold at the
            time of the Distribution, adjusted for stock splits, stock dividends
            recapitalizations and the like; and

        2.  All holders of the Issuer's EQUITY SECURITIES shall thereafter
            participate on an equal, per share basis times the number of shares
            of EQUITY SECURITIES they hold at the time of the Distribution,
            adjusted for stock splits, stock dividends, recapitalizations and
            the like.

        3.  The Distribution may proceed on lesser terms and conditions than
            the terms and conditions stated in paragraphs 1 and 2 above if a
            majority of the EQUITY SECURITIES that are not held by Security
            Holders, officers, directors, or Promoters of the Issuer, or their
            associates or affiliates vote, or consent by consent procedure, to
            approve the lesser terms and conditions.

     B. In the event of a dissolution, liquidation, merger, consolidation,
        reorganization, sale or exchange of the Issuer's assets or securities
        (including by way of tender offer), or any other transaction or
        proceeding with a person who is a Promoter, which results in a
        Distribution while this Agreement remains in effect, the Restricted
        Securities shall remain subject to the terms of this Agreement.

     C. Restricted Securities may be transferred by will, the laws of descent
        and distribution, the operation of law, or by order of any court of
        competent jurisdiction and proper venue.

     D. Restricted Securities of a deceased Security Holder may be hypothecated
        to pay the expenses of the deceased Security Holder's estate. The
        hypothecated Restricted Securities shall remain subject to the terms of
        this Agreement. Restricted Securities may not be pledged to secure any
        other debt.

                                      -2-

<PAGE>


     E. Restricted Securities may be transferred by gift to the Security
        Holder's family members, provided that the Restricted Securities shall
        remain subject to the terms of this Agreement.

     F. With the exception of paragraph A.3 above, the Restricted Securities
        shall have the same voting rights as similar EQUITY SECURITIES not
        subject to the Agreement.

     G. A notice shall be placed on the face of each stock certificate of the
        Restricted Securities covered by the terms of the Agreement stating that
        the transfer of the stock evidenced by the certificate is restricted in
        accordance with the conditions set forth on the reverse side of the
        certificate; and

     H. A typed legend shall be placed on the reverse side of each stock
        certificate of the Restricted Securities representing stock covered by
        the Agreement which states that the sale or transfer of the shares
        evidenced by the certificate is subject to certain restrictions until
        the second anniversary of the completion of the public offering pursuant
        to an agreement between the Security Holder (whether beneficial or of
        record) and the Issuer, which agreement is on file with the Issuer and
        the stock transfer agent from which a copy is available upon request and
        without charge.

     I. The terms of this Agreement shall begin on the date that the
        Registration is declared effective by the Commission ("Effective Date")
        and shall terminate:

        1.  On the anniversary of the second year from the completion date of
            the public offering; or

        2.  On the date the Registration has been terminated if no securities
            were sold pursuant thereto; or

        3.  If the Registration has been terminated, the date that checks
            representing all of the gross proceeds that were derived therefrom
            and addressed to the public investors have been placed in the U.S.
            Postal Service with first class postage affixed; or

        4.  On the date the securities subject to this Agreement become "Covered
            Securities," as defined under the National Securities Markets
            Improvement Act of 1996.

     J. This Agreement to be modified only with the written approval of the
        Commission.

IV.  THEREFORE, the Issuer will cause the following:

     A. A manually signed copy of the Agreement signed by the Signatories to be
        filed with the Commission prior the Effective Date;

                                       -3-

<PAGE>


     B. Copies of the Agreement and a statement of the per share initial public
        offering price to be provided to the Issuer's stock transfer agent;

     C. Appropriate stock transfer orders to be placed with the Issuer's stock
        transfer agent against the sale or transfer of the shares covered by the
        Agreement prior to its expiration, except as may otherwise be provided
        in this Agreement;

     D. The above stock restriction legends to be placed on the periodic
        statement sent to the registered owner if the securities subject to this
        Agreement are uncertificated securities.

Pursuant to the requirements of this Agreement, the Signatories have entered
into this Agreement, which may be written in multiple counterparts and each of
which shall be considered an original. The Signatories have signed the Agreement
in the capacities, and on the dates, indicated.

V.  The Security Holder understands and agrees that this agreement runs
    concurrently with, and does not replace, the Security Holder's agreement
    with First Montauk Securities Corp. (the "Underwriter") pursuant to which
    the Security Holder has agreed to not sell any shares of Common Stock owned
    by the Security Holder for one year from the effective date of the
    Registration without the consent of the Underwriter, and further understands
    that the Underwriter has represented to and agreed with the Commission that
    it will not release any of the shares owned by the Security Holder for sale
    during the one year period contemplated thereby.

IN WITNESS WHEREOF, the Signatories have executed this Agreement.

(ISSUER'S NAME)

By
  ----------------------------------

- ------------------------------------
    President

- ------------------------------------
Signature

- ------------------------------------
Printed Name of Security Holder

- ------------------------------------
Title, if Applicable


                                      -4-




FIRST MONTAUK SECURITIES CORP.
Attn: Robert Rabinowitz, Esquire
328 Newman Springs Road
Red Bank, NJ 07701

Re: Agreement Not to Sell

Ladies and Gentlemen:

        Reference is made to the proposed initial public offering of shares of
Common Stock of PacificHealth Laboratories, Inc. (the "Company") to be made
pursuant to a Registration Statement (the "Registration Statement") filed with
the Securities and Exchange Commission on September 25, 1997, which offering is
being underwritten by First Montauk Securities Corp. (the "Underwriter").

        Intending to be legally bound hereby, the undersigned agrees that,
without the express prior written consent of the Underwriter, he or she will not
offer, sell, make any short sale of, loan, encumber, grant any option for the
purchase of, or otherwise dispose of (the "Resale Restrictions") any shares of
common stock of the Company beneficially owned or otherwise held by the
undersigned as of the date of this letter or hereafter acquired from the Company
by the undersigned (collectively, the "Shares") for a period of one year after
the effective date of the Registration Statement (the "Lock-up Period"). The
Resale Restrictions are intended and agreed to preclude the undersigned from
engaging in any hedging or other transaction which may lead to or result in a
sale of Shares during the Lock-up Period even if such Shares would be sold by
someone other than the undersigned. Such prohibited hedging or other
transactions would include without limitation any short sale (whether or not
against the box), any pledge or any purchase, sale or grant of any right
(including without limitation any put or call option) with respect to any of the
Shares.

        The undersigned agrees and consents to the entry of stop transfer
instructions with the transfer agent for the Company's Common Stock against any
transfer of shares of Common Stock by the undersigned in contravention of the
Resale Restrictions. The undersigned understands that the Underwriter and the
Company will rely upon the representations set forth in this letter in
proceeding with the public offering, and that the agreements of the undersigned
set forth herein are irrevocable and shall be binding upon the undersigned's
heirs, legal representatives, successors and assigns.

        Notwithstanding the foregoing, the undersigned may transfer any or all
of the Shares either during his or her lifetime or on death by will or intestacy
to his or her immediate family or to a trust the beneficiaries of which are
exclusively the undersigned and/or a member or members of his or her immediate


<PAGE>


family; provided, however, that in any such case it shall be a condition to any
such transfer that the transferee execute an agreement stating that the
transferee is receiving and holding the Shares subject to the provisions of this
Lock-up Agreement, and that no further transfer of such Shares shall be made
except in accordance with this Lock-up Agreement. For purposes of this
paragraph, "immediate family" shall mean spouse, lineal descendant, father,
mother, brother or sister of the transferor.


                                       Very truly yours,

                                       By:
                                          -----------------------------------
                                          Signature(s)

                                         ------------------------------------
                                         Printed name(s) of person(s) signing

Accepted and Agreed to:

FIRST MONTAUK SECURITIES CORP.

By:
   ---------------------------------

Title:
      ------------------------------




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission